Broadwood slams STAAR board over “carelessness” in Alcon sale defense

Broadwood slams STAAR board over “carelessness” in Alcon sale defense

Investing.com — STAAR Surgical’s (NASDAQ:STAA) largest shareholder, Broadwood Partners, has renewed its criticism of the company’s board ahead of the October 23 vote on its $28-per-share sale to Alcon (NYSE:ALC), accusing directors of…

Continue Reading